Literature DB >> 18566587

Essential function of TORC2 in PKC and Akt turn motif phosphorylation, maturation and signalling.

Tsuneo Ikenoue1, Ken Inoki, Qian Yang, Xiaoming Zhou, Kun-Liang Guan.   

Abstract

Protein kinase C (PKC) is involved in a wide array of cellular processes such as cell proliferation, differentiation and apoptosis. Phosphorylation of both turn motif (TM) and hydrophobic motif (HM) are important for PKC function. Here, we show that the mammalian target of rapamycin complex 2 (mTORC2) has an important function in phosphorylation of both TM and HM in all conventional PKCs, novel PKCepsilon as well as Akt. Ablation of mTORC2 components (Rictor, Sin1 or mTOR) abolished phosphorylation on the TM of both PKCalpha and Akt and HM of Akt and decreased HM phosphorylation of PKCalpha. Interestingly, the mTORC2-dependent TM phosphorylation is essential for PKCalpha maturation, stability and signalling. Our study demonstrates that mTORC2 is involved in post-translational processing of PKC by facilitating TM and HM phosphorylation and reveals a novel function of mTORC2 in cellular regulation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18566587      PMCID: PMC2486275          DOI: 10.1038/emboj.2008.119

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  42 in total

Review 1.  Multiple pathways control protein kinase C phosphorylation.

Authors:  D B Parekh; W Ziegler; P J Parker
Journal:  EMBO J       Date:  2000-02-15       Impact factor: 11.598

2.  The turn motif is a phosphorylation switch that regulates the binding of Hsp70 to protein kinase C.

Authors:  Tianyan Gao; Alexandra C Newton
Journal:  J Biol Chem       Date:  2002-06-21       Impact factor: 5.157

Review 3.  Cell polarity: Par6, aPKC and cytoskeletal crosstalk.

Authors:  Sandrine Etienne-Manneville; Alan Hall
Journal:  Curr Opin Cell Biol       Date:  2003-02       Impact factor: 8.382

4.  Two TOR complexes, only one of which is rapamycin sensitive, have distinct roles in cell growth control.

Authors:  Robbie Loewith; Estela Jacinto; Stephan Wullschleger; Anja Lorberg; José L Crespo; Débora Bonenfant; Wolfgang Oppliger; Paul Jenoe; Michael N Hall
Journal:  Mol Cell       Date:  2002-09       Impact factor: 17.970

5.  Mammalian TOR controls one of two kinase pathways acting upon nPKCdelta and nPKCepsilon.

Authors:  D Parekh; W Ziegler; K Yonezawa; K Hara; P J Parker
Journal:  J Biol Chem       Date:  1999-12-03       Impact factor: 5.157

6.  Direct inhibition of the signaling functions of the mammalian target of rapamycin by the phosphoinositide 3-kinase inhibitors, wortmannin and LY294002.

Authors:  G J Brunn; J Williams; C Sabers; G Wiederrecht; J C Lawrence; R T Abraham
Journal:  EMBO J       Date:  1996-10-01       Impact factor: 11.598

7.  Regulation of novel protein kinase C epsilon by phosphorylation.

Authors:  Vittoria Cenni; Heike Döppler; Erica D Sonnenburg; Nadir Maraldi; Alexandra C Newton; Alex Toker
Journal:  Biochem J       Date:  2002-05-01       Impact factor: 3.857

8.  Phosphorylation of Thr642 is an early event in the processing of newly synthesized protein kinase C beta 1 and is essential for its activation.

Authors:  J Zhang; L Wang; J Schwartz; R W Bond; W R Bishop
Journal:  J Biol Chem       Date:  1994-07-29       Impact factor: 5.157

9.  Molecular cloning, characterization, and expression of a cDNA encoding the "80- to 87-kDa" myristoylated alanine-rich C kinase substrate: a major cellular substrate for protein kinase C.

Authors:  D J Stumpo; J M Graff; K A Albert; P Greengard; P J Blackshear
Journal:  Proc Natl Acad Sci U S A       Date:  1989-06       Impact factor: 11.205

Review 10.  PKB/Akt: a key mediator of cell proliferation, survival and insulin responses?

Authors:  M A Lawlor; D R Alessi
Journal:  J Cell Sci       Date:  2001-08       Impact factor: 5.285

View more
  323 in total

Review 1.  Tuning the signalling output of protein kinase C.

Authors:  Corina E Antal; Alexandra C Newton
Journal:  Biochem Soc Trans       Date:  2014-12       Impact factor: 5.407

2.  Oncogenic EGFR signaling activates an mTORC2-NF-κB pathway that promotes chemotherapy resistance.

Authors:  Kazuhiro Tanaka; Ivan Babic; David Nathanson; David Akhavan; Deliang Guo; Beatrice Gini; Julie Dang; Shaojun Zhu; Huijun Yang; Jason De Jesus; Ali Nael Amzajerdi; Yinan Zhang; Christian C Dibble; Hancai Dan; Amanda Rinkenbaugh; William H Yong; Harry V Vinters; Joseph F Gera; Webster K Cavenee; Timothy F Cloughesy; Brendan D Manning; Albert S Baldwin; Paul S Mischel
Journal:  Cancer Discov       Date:  2011-09-13       Impact factor: 39.397

Review 3.  Deconvoluting mTOR biology.

Authors:  Jason D Weber; David H Gutmann
Journal:  Cell Cycle       Date:  2012-01-15       Impact factor: 4.534

4.  Peptidyl-prolyl isomerase Pin1 controls down-regulation of conventional protein kinase C isozymes.

Authors:  Hilde Abrahamsen; Audrey K O'Neill; Natarajan Kannan; Nicole Kruse; Susan S Taylor; Patricia A Jennings; Alexandra C Newton
Journal:  J Biol Chem       Date:  2012-02-08       Impact factor: 5.157

Review 5.  Mitochondrial regulation of cell cycle and proliferation.

Authors:  Valeria Gabriela Antico Arciuch; María Eugenia Elguero; Juan José Poderoso; María Cecilia Carreras
Journal:  Antioxid Redox Signal       Date:  2012-01-13       Impact factor: 8.401

6.  EGFR signals to mTOR through PKC and independently of Akt in glioma.

Authors:  Qi-Wen Fan; Christine Cheng; Zachary A Knight; Daphne Haas-Kogan; David Stokoe; C David James; Frank McCormick; Kevan M Shokat; William A Weiss
Journal:  Sci Signal       Date:  2009-01-27       Impact factor: 8.192

7.  mTOR complex 2 phosphorylates IMP1 cotranslationally to promote IGF2 production and the proliferation of mouse embryonic fibroblasts.

Authors:  Ning Dai; Jan Christiansen; Finn C Nielsen; Joseph Avruch
Journal:  Genes Dev       Date:  2013-02-01       Impact factor: 11.361

8.  mTOR signaling and transcriptional regulation in T lymphocytes.

Authors:  Hu Zeng; Hongbo Chi
Journal:  Transcription       Date:  2014

9.  XPLN is an endogenous inhibitor of mTORC2.

Authors:  Nidhi Khanna; Yimin Fang; Mee-Sup Yoon; Jie Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2013-09-16       Impact factor: 11.205

Review 10.  AKT/PKB Signaling: Navigating the Network.

Authors:  Brendan D Manning; Alex Toker
Journal:  Cell       Date:  2017-04-20       Impact factor: 41.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.